L-Phosphinothricin Synthesis via Enzymatic Cascade
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing L-phosphinothricin face challenges such as high costs due to expensive chiral raw materials, low conversion rates, and the use of highly toxic cyanides, which hinder industrial scalability and environmental sustainability.
Innovation Solution
A chemical-biological cascade synthesis method using diethoxymethylphosphine, acrylic acid, and sodium ethoxide to produce 4-(hydroxymethylphosphinyl)-2-oxobutyric acid, followed by enzymatic conversion with a phosphinothricin dehydrogenase mutant and alcohol dehydrogenase, eliminating the need for toxic cyanides and achieving high conversion rates and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If chemical synthesis using traditional routes is used, then L-phosphinothricin can be produced, but highly toxic cyanide is required and waste production is high
Solution Approach 1:
The patent converts the harmful cyanide-based chemical synthesis into a beneficial enzymatic process. By using phosphinothricin dehydrogenase and alcohol dehydrogenase enzymes, the method eliminates toxic cyanide while achieving high conversion rates through biological catalysis, transforming a harmful process into an environmentally friendly one
Solution Approach 2:
The patent replaces the chemical synthesis mechanism with a biological enzymatic mechanism. Instead of using chemical reagents that generate toxic waste, the method employs enzyme-catalyzed reactions that proceed with high specificity and efficiency, substituting chemical mechanics with biological catalysis
2Manufacturing precision
If enzymatic synthesis using existing enzymes is used, then L-phosphinothricin can be produced with high stereoselectivity, but the conversion rate is low and costs are high due to expensive chiral raw materials
Solution Approach 1:
The patent merges two enzymatic systems into a cascade reaction: phosphinothricin dehydrogenase and alcohol dehydrogenase work together in sequence. This combination allows the first enzyme to establish stereoselectivity while the second enzyme drives the reaction to completion with high conversion, achieving both precision and productivity
Solution Approach 2:
The patent implements continuous enzymatic action through a cascade mechanism where the product of the first enzyme reaction serves as the substrate for the second enzyme. This continuous processing eliminates intermediates and maintains high conversion rates while preserving stereoselectivity throughout the transformation
3Manufacturing precision
If racemic phosphinothricin is produced and then resolved, then L-phosphinothricin can be obtained, but the theoretical yield is limited to 50% and raw materials are wasted
Solution Approach 1:
The patent performs preliminary chiral induction during the synthesis process itself rather than after. By using chiral enzymes that inherently produce only the L-enantiomer from the start, the method avoids the need for subsequent resolution steps, achieving 100% yield of the desired enantiomer without wasting half the raw materials
4Manufacturing precision
If multiple enzymatic steps are used in sequence, then L-phosphinothricin can be synthesized with high purity, but the process complexity increases
Solution Approach 1:
The patent merges multiple enzymatic functions into a coordinated cascade system where phosphinothricin dehydrogenase and alcohol dehydrogenase operate in sequence. This integration achieves high purity through sequential transformations while managing complexity through functional synergy rather than separate independent steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method reduces waste production by over 50%, achieves a 100% conversion rate, and simplifies the synthesis process, making it environmentally friendly and suitable for industrial-scale continuous production while maintaining high enantiomeric excess (>99%) of L-phosphinothricin.
Implementation Method 1
using highly active and stable wet cells co-expressing phsophinothricin dehydrogenase and alcohol dehydrogenase or co-expressing a phsophinothricin dehydrogenase mutant and alcohol dehydrogenase as a biocatalyst
Implementation Method 2
co-expressing phsophinothricin dehydrogenase and alcohol dehydrogenase or co-expressing a phsophinothricin dehydrogenase mutant and alcohol dehydrogenase as a biocatalyst
Implementation Method 3
a condensation reaction is carried out with 3-(methylethoxyphosphinyl) ethyl propionate and sodium ethoxide as reactants
Implementation Method 4
the product is subjected to a hydrolysis reaction with diethyl oxalate to synthesize 4-(hydroxymethylphosphinyl)-2-oxobutyric acid
Data Source
AI summary
A method for chemical-biological cascade synthesis of L-phosphinothricin is carried out as follows: 3-(methylethoxyphosphinyl) ethyl propionate is synthesized by addition reaction from diethoxymethylphosphine and acrylic acid, then a condensation reaction is carried out with 3-(methylethoxyphosphinyl) ethyl propionate and sodium ethoxide as reactants, then the product is subjected to a hydrolysis reaction with diethyl oxalate to synthesize 4-(hydroxymethylphosphinyl)-2-oxobutyric acid, and finally, L-phosphinothricin is catalytically synthesized by taking 4-(hydroxymethylphosphinyl)-2-oxobutyric acid as a raw material, and using highly active and stable wet cells co-expressing phsophinothricin dehydrogenase and alcohol dehydrogenase or co-expressing a phsophinothricin dehydrogenase mutant and alcohol dehydrogenase as a biocatalyst, thereby solving the problems of existing L-phosphinothricin synthesis being tedious, low asymmetric amination reduction activity and poor stability.